Answers are grounded in this paper and cite their sources.
The host's overall immune status, and not only the tumor itself, should be considered to predict the efficacy of immunotherapy in cancer patients. This study is the first to show the significant prognostic value of memory CD8(+) T cells in immunotherapy of cancer patients through systematic review and meta-analysis. Thus, the detection of memory CD8(+) T cells has a considerable value in clinical practice in cancer patients with immunotherapy. Memory CD8(+) T cells may be promising immunotherapy targets.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: